Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are the same because they are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies have monovalent affinity, in that they bind to the same epitope.
Given almost any substance, it is possible to produce monoclonal antibodies that specifically bind to that substance; they can then serve to detect or purify that substance. This has becom...
More
Read article at Wikipedia
Monoclonal Antibody
Award-Winning Work
Awards Won:
| Year | Award | Award Winner | Notes/Description |
|---|---|---|---|
|
|
Nobel Prize in Physiology or Medicine Winners
- 1981
- 1982
- 1983
- 1984
- 1985
- 1986
- 1987
- 1989
Facts from the Community
From the BioVenturist base
Products involving this technology:
- Rituximab
- Trastuzumab
- Palivizumab
- Adalimumab
- Bevacizumab
- Abciximab
- Omalizumab
- Alemtuzumab
- Muromonab
- Efalizumab
Company involved:
- Genentech
- Amgen
- MacroGenics
- MedImmune
- Medarex
- Ablynx
- Human Genome Sciences
- BioInvent
- KaloBios
- Aeres Biomedical
Patents:
- WO 200563817
- WO 200563335
- WO 200563292
- WO 200562955
- WO 200562893
- US 20050152902
- WO 200560999
- WO 200560641
- US 20050142620
- JP 2005172546
Parent Technology:
Includes Technology:
- Murine Monoclonal Antibody
- Human Monoclonal Antibody
- Chimeric Monoclonal Antibody
- Humanized Monoclonal Antibody